Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Inspire Singapore Study

NCT: NCT06540716 · COMPLETED

NCT IDNCT06540716
StatusCOMPLETED
Start Date2024-07-25
Completion2025-12-01

Brief Summary

Prospective, multicenter, open-label study designed to confirm device performance of Inspire system in Singapore.

Frequently Asked Questions

What is Inspire Singapore Study?

Inspire Singapore Study is a clinical trial registered under NCT06540716. Current status: COMPLETED.

What is the status of NCT06540716?

The current status of NCT06540716 (Inspire Singapore Study) is: COMPLETED.

When did Inspire Singapore Study start?

Inspire Singapore Study started on 2024-07-25.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.